TKNO
|
$2.155
-17.12%
-20.65%
7.4K
|
Professional, Scientific, and T...
(0.0% 1d)
(-24.9% 1m)
(-0.5% 1y)
(0.0% 2d)
(-18.8% 3d)
(-12.4% 7d)
(952.9%
volume)
Earnings Calendar: 2024-03-11
Market Cap: $ 87,974,399
https://www.teknova.com
Sec
Filling
|
Patents
| 193 employees
Teknova is expediting clinical breakthroughs in the life sciences by providing custom products and reagents for bioprocessing, bioproduction, and molecular diagnostics. With a focus on agility and customization, Teknova delivers research-grade and GMP products including cell culture media and supplements, protein and nucleic acid purification buffers, and molecular biology reagents for a multitude of established and emerging applications, including cell and gene therapy, mRNA therapeutics, genomics, and synthetic biology. Teknova's proprietary processes enable the manufacture and delivery of high quality, custom, made-to-order products on short turnaround times and at scale across all stages of development, including commercialization.
diagnostics
gene therapies
t-cell
add to watch list
Paper trade
email alert is off
Press-releases
Teknova Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-11
(Crawled : 20:00)
- globenewswire.com
TKNO
|
$2.155
-17.12%
-20.65%
7.4K
|
Professional, Scientific, and T...
| -30.13%
| O: -5.25%
H: 4.45%
C: -0.4%
year
financial
results
Teknova to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
Published: 2024-02-21
(Crawled : 21:00)
- globenewswire.com
TKNO
|
$2.155
-17.12%
-20.65%
7.4K
|
Professional, Scientific, and T...
| -29.67%
| O: 0.0%
H: 5.5%
C: -2.33%
report
year
financial
results
Teknova Reports Third Quarter 2023 Financial Results
Published: 2023-11-09
(Crawled : 21:00)
- globenewswire.com
TKNO
|
$2.155
-17.12%
-20.65%
7.4K
|
Professional, Scientific, and T...
| 4.98%
| O: -1.49%
H: 4.04%
C: -1.52%
financial
results
Teknova to Report Third Quarter 2023 Financial Results on November 9, 2023
Published: 2023-10-26
(Crawled : 12:00)
- globenewswire.com
TKNO
|
$2.155
-17.12%
-20.65%
7.4K
|
Professional, Scientific, and T...
| 13.44%
| O: 4.84%
H: 11.28%
C: -2.56%
report
financial
results
Teknova Launches Latest Proprietary AAV-Tek™ Product and End-to-End Plasmid Workflow Solutions to Streamline Therapeutic Process Development
Published: 2023-09-27
(Crawled : 12:00)
- globenewswire.com
TKNO
|
$2.155
-17.12%
-20.65%
7.4K
|
Professional, Scientific, and T...
| -27.74%
| O: 31.85%
H: 10.91%
C: -19.74%
solutions
Teknova Announces Closing of $22.9 Million Concurrent Registered Direct Offering and Private Placement and Amends Credit Facility
Published: 2023-09-19
(Crawled : 20:00)
- globenewswire.com
TKNO
|
$2.155
-17.12%
-20.65%
7.4K
|
Professional, Scientific, and T...
| 17.88%
| O: 1.68%
H: 8.79%
C: 3.3%
direct
offering
Teknova Announces Up to $22.9 Million Concurrent Registered Direct Offering and Private Placement
Published: 2023-09-18
(Crawled : 12:00)
- globenewswire.com
TKNO
|
$2.155
-17.12%
-20.65%
7.4K
|
Professional, Scientific, and T...
| 14.05%
| O: -5.41%
H: 7.71%
C: 2.29%
direct
offering
Teknova Announces New Board Member, Martha J. Demski
Published: 2023-08-16
(Crawled : 12:00)
- globenewswire.com
TKNO
|
$2.155
-17.12%
-20.65%
7.4K
|
Professional, Scientific, and T...
| -24.1%
| O: -2.16%
H: 9.19%
C: 3.31%
EQ
|
$1.79
-3.24%
0.0%
93K
|
Health Technology
| 145.03%
| O: -4.37%
H: 14.96%
C: 13.57%
CMRX
|
$0.904
-1.75%
-2.23%
480K
|
Health Technology
| -7.9%
| O: -1.9%
H: 4.08%
C: -2.04%
Teknova Reports Second Quarter 2023 Financial Results
Published: 2023-08-10
(Crawled : 20:00)
- globenewswire.com
TKNO
|
$2.155
-17.12%
-20.65%
7.4K
|
Professional, Scientific, and T...
| -24.64%
| O: -4.64%
H: 7.12%
C: 7.12%
financial
results
Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents
Published: 2023-08-09
(Crawled : 12:00)
- globenewswire.com
TKNO
|
$2.155
-17.12%
-20.65%
7.4K
|
Professional, Scientific, and T...
| -28.23%
| O: 0.0%
H: 1.7%
C: -10.88%
life
capacity
sciences
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001850902-23-000045
4
2023-12-01
2023-11-30
Buy
P
3587
22924
0001850902-23-000043
4
2023-11-15
2023-11-14
Sell
J
15000
18834